Medicxi Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
15
- Investments
-
79
- Portfolio
-
31
- Exits
-
35
Medicxi General Information
Company Description
Founded in 2016, Medicxi is a venture capital firm based in London, United Kingdom. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in healthcare, life sciences, and technology-based sectors in Europe.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- 25 Great Pulteney Street
- London W1F 9LT
- England, United Kingdom
Medicxi Investments (79)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| D3 Bio | 08-Apr-2024 | Early Stage VC | 0000 | Biotechnology | Product Development | |
| Petalion Therapeutics | 08-Apr-2024 | 00000 000000 | 0000 | Drug Discovery | Startup | |
| Alys Pharmaceuticals | 12-Feb-2024 | 0000 00000 | 00000 | Biotechnology | Startup | 000000000 00 |
| ProfoundBio | 09-Feb-2024 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 2 | |
| Takeda Pharmaceutical Company | 24-Jan-2024 | 0000 | Pharmaceuticals | Profitable | ||
| Fore Biotherapeutics | 09-Aug-2023 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 00000000 000 |
| T-Cypher Bio | 29-Jun-2023 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| Altesa BioSciences | 22-Jun-2023 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | |
| Granular Therapeutics | 07-Jun-2023 | Later Stage VC | 00.000 | Drug Discovery | Pre-Clinical Trials | 000000000 00 |
| Graegis Pharmaceuticals | 06-Dec-2022 | Early Stage VC | 000.00 | Drug Delivery | Clinical Trials - General |
Medicxi Exits (35)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Kymo Therapeutics | 16-Jul-2024 | Out of Business | |
| ProfoundBio | 21-May-2024 | 000000000000 | 00.00 |
| Centessa Pharmaceuticals | 25-Apr-2024 | 000000 00000 | 00000 |
| Granular Therapeutics | 12-Feb-2024 | 000000000000 | |
| UltraHuman (Drug Discovery) | 31-Jan-2024 | 000 00 00000 | |
| Gadeta | 02-Oct-2023 | 000000000000 | |
| Versanis Bio | 14-Aug-2023 | 000000000000 | 00.000 |
| Pandeia Therapeutics | 01-Dec-2022 | 000000000000 | |
| Villaris Therapeutics | 17-Nov-2022 | Merger/Acquisition | 00.000 |
| MiroBio | 20-Sep-2022 | Merger/Acquisition | 00000 |
Medicxi Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Medicxi Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Medicxi Management, Team & Partners (33)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Kevin Johnson Ph.D | Co-Founder & Venture Partner | 00 | 0 | 0 | London, United Kingdom |
| Michèle Ollier MD | Co-Founder & Venture Partner | 00 | 0 | 0 | Geneva, Switzerland |
| Charles Grummitt Ph.D | Venture Partner | London, United Kingdom | |||
| Thibaut De Smedt Ph.D | Venture Partner | London, United Kingdom | |||
| Francesco De Rubertis Ph.D | Co-Founder & Partner | 00 | 0 | 0 | Geneva, Switzerland |
Medicxi Co-Investors (92)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 5 | 0 | 0 |
|
|
| Longitude Capital | 0 | 0 |
|
|
|
| Roche Venture Fund | 0 | 0 | 0 |
|
|
| Advent Life Sciences | 0 | 0 | 0 |
|
|
| OrbiMed | 0 | 0 | 0 |
|
|
Medicxi FAQs
-
What is Medicxi?
Founded in 2016, Medicxi is a venture capital firm based in London, United Kingdom.
-
When was Medicxi founded?
Medicxi was founded in 2016.
-
Who is the founder of Medicxi?
Kevin Johnson Ph.D, Michèle Ollier MD, Francesco De Rubertis Ph.D, Giovanni Pericolini, Giovanni Mariggi Ph.D, Richard Lee, Rémy Luthringer Ph.D, Giuseppe Zocco, and David Grainger Ph.D are the founders of Medicxi.
-
Where is Medicxi headquartered?
Medicxi is headquartered in London, United Kingdom.
-
How many investments has Medicxi made?
Medicxi has made 79 investments.
-
What has Medicxi invested in?
Medicxi has made numerous investments in companies like D3 Bio, Petalion Therapeutics, and Alys Pharmaceuticals within the Biotechnology and Drug Discovery industries.
-
What has Medicxi invested in recently?
Medicxi's latest investment was on 08-Apr-2024 in D3 Bio, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
